Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea Pollen

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The objective of this trial is to assess the clinical efficacy of a modified allergen extract of Olea europaea pollen in the treatment of patients affected by allergic rhinitis/rhinoconjunctivitis (with or without episodic asthma) induced by hypersensitivity to olea europaea pollen, evaluating the Score regarding Symptoms and consumption of the medication.
Epistemonikos ID: ccd0a53255e216dbdba243d3cb307b20c727b577
First added on: May 05, 2024